Free Access
Med Sci (Paris)
Volume 26, Number 10, Octobre 2010
Page(s) 861 - 868
Section M/S revues
Published online 15 October 2010
  1. Gupta P, Leroux C, Patterson BK, et al. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral quasi species between blood and semen. J Infect Dis 2000 ; 182 : 79-87. [Google Scholar]
  2. Le Tortorec A, Dejucq-Rainsford N. HIV infection of the male genital tract - consequences for sexual transmission and reproduction. Int J Androl 2009 ; 32 : 1-12. [Google Scholar]
  3. Paranjpe S, Craigo J, Patterson B, et al. Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. AIDS Res Hum Retrovir 2002 ; 18 : 1271-80. [Google Scholar]
  4. Ghosn J, Viard JP, Katlama C, et al. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men. AIDS 2004 ; 18 : 447-57. [Google Scholar]
  5. Dejucq N, Jegou B. Viruses in the mammalian male genital tract and their effects on the reproductive system. Microbiol Mol Biol Rev 2001 ; 65 : 208-31. [Google Scholar]
  6. Munch J, Rucker E, Standker L, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007 ; 131 : 1059-71. [Google Scholar]
  7. Maher D, Wu X, Schacker T, et al. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc Natl Acad Sci USA 2005 ; 102 : 11504-9. [Google Scholar]
  8. Roan NR, Sowinski S, Munch J, et al. Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J Biol Chem 2010 ; 285 : 1861-9. [Google Scholar]
  9. Sabatte J, Ceballos A, Raiden S, et al. Human seminal plasma abrogates the capture and transmission of human immunodeficiency virus type 1 to CD4+ T cells mediated by DC-SIGN. J Virol 2007 ; 81 : 13723-34. [Google Scholar]
  10. Martellini JA, Cole AL, Venkataraman N, et al. Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma. FASEB J 2009 ; 23 : 3609-18. [Google Scholar]
  11. Cherrier T, Le Douce V, Redel L, et al. Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. Partie II : la réactivation de la latence du VIH-1 et ses implications thérapeutiques. Med Sci (Paris) 2010 ; 26 : 291-5. [Google Scholar]
  12. Schwartz C, Le Douce V, Cherrier T, et al. Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. Partie I : la physiologie de la latence du VIH-1. Med Sci (Paris) 2010 ; 26 : 159-63 [Google Scholar]
  13. Estaquier J, Hurtrel B. Sanctuaire du virus de l’immunodéficience humaine et mécanismes d’échappement. Med Sci (Paris) 2008 ; 24 : 1055-60. [Google Scholar]
  14. Cherrier T, Le Douce V, Redel L, et al. Un virus tapi dans l’ombre : les bases moléculaires de la latence du VIH-1. Partie II : la réactivation de la latence du VIH-1 et ses implications thérapeutiques. Med Sci (Paris) 2010 ; 26 : 291-6. [Google Scholar]
  15. Leruez-Ville M, Dulioust E, Costabliola D, et al. Decrease in HIV-1 seminal shedding in men receiving highly active antiretroviral therapy: an 18 month longitudinal study (ANRS EP012). AIDS 2002 ; 16 : 486-8. [Google Scholar]
  16. Sheth PM, Kovacs C, Kemal KS, et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 2009 ; 23 : 2050-4. [Google Scholar]
  17. Marcelin AG, Tubiana R, Lambert-Niclot S, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 2008 ; 22 : 1677-9. [Google Scholar]
  18. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai project study group. N Engl J Med 2000 ; 342 : 921-9. [Google Scholar]
  19. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009 ; 23 : 1397-404. [Google Scholar]
  20. Sturmer M, Doerr HW, Berger A, Gute P. Is transmission of HIV-1 in nonviraemic serodiscordant couples possible? Antivir Ther 2008 ; 13 : 729-32. [Google Scholar]
  21. Wilson DP, Law MG, Grulich AE, et al. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008 ; 372 : 314-20. [Google Scholar]
  22. Legeai C, Auvert B. La circoncision : un espoir de réduction de l’infection à VIH en Afrique australe. Med Sci (Paris) 2008 ; 24 : 499-504. [Google Scholar]
  23. Bujan L, Hollander L, Coudert M, et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007 ; 21 : 1909-14. [Google Scholar]
  24. Dulioust E, Du AL, Costagliola D, et al. Semen alterations in HIV-1 infected men. Hum Reprod 2002 ; 17 : 2112-8. [Google Scholar]
  25. Bujan L, Sergerie M, Moinard N, et al. Decreased semen volume and spermatozoa motility in HIV-1 infected patients under antiretroviral treatment. J Androl 2007 ; 28 : 444-52. [Google Scholar]
  26. van Leeuwen E, Wit FW, Repping S, et al. Effects of antiretroviral therapy on semen quality. AIDS 2008 ; 22 : 637-42. [Google Scholar]
  27. Dussaix E, Guetard D, Dauguet C, et al. Spermatozoa as potential carriers of HIV. Res Virol 1993 ; 144 : 487-95. [Google Scholar]
  28. Ceballos A, Remes Lenicov F, Sabatte J, et al. Spermatozoa capture HIV-1 through heparan sulfate and efficiently transmit the virus to dendritic cells. J Exp Med 2009 ; 206 : 2717-33. [Google Scholar]
  29. Muciaccia B, Corallini S, Vicini E, et al. HIV-1 viral DNA is present in ejaculated abnormal spermatozoa of seropositive subjects. Hum Reprod 2007 ; 22 : 2868-78. [Google Scholar]
  30. Roulet V, Denis H, Staub C, et al. Human testis in organotypic culture: application for basic or clinical research. Hum Reprod 2006 ; 21 : 1564-75. [Google Scholar]
  31. Roulet V, Satie AP, Ruffault A, et al. Susceptibility of human testis to human immunodeficiency virus-1 infection in situ and in vitro. Am J Pathol 2006 ; 169 : 2094-103. [Google Scholar]
  32. Le Tortorec A, Le Grand R, Denis H, et al. Infection of semen-producing organs by SIV during the acute and chronic stages of the disease. PLoS One 2008 ; 3 : e1792. [Google Scholar]
  33. Shehu-Xhilaga M, Kent S, Batten J, et al. The testis and epididymis are productively infected by SIV and SHIV in juvenile macaques during the postacute stage of infection. Retrovirology 2007 ; 4 : 7. [Google Scholar]
  34. Muciaccia B, Filippini A, Ziparo E, et al. Testicular germ cells of HIV- seropositive asymptomatic men are infected by the virus. J Reprod Immunol 1998 ; 41 : 81-93. [Google Scholar]
  35. Smith DM, Kingery JD, Wong JK, et al. The prostate as a reservoir for HIV-1. AIDS 2004 ; 18 : 1600-2. [Google Scholar]
  36. Le Tortorec A, Satie AP, Denis H, et al. Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo. Retrovirology 2008 ; 5 : 119. [Google Scholar]
  37. Kiessling AA, Fitzgerald LM, Zhang D, et al. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Res Hum Retrovir 1998 ; 14 : S33-41. [Google Scholar]
  38. Mayer KH, Boswell S, Goldstein R, et al. Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 1999 ; 28 : 1252-9. [Google Scholar]
  39. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998 ; 339 : 1803-9. [Google Scholar]
  40. Vernazza PL, Troiani L, Flepp MJ, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV cohort study. Aids 2000 ; 14 : 117-21. [Google Scholar]
  41. Gunthard HF, Havlir DV, Fiscus S, et al. Residual human immunodeficiency virus (HIV) type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. J Infect Dis 2001 ; 183 : 1318-27. [Google Scholar]
  42. Lafeuillade A, Solas C, Halfon P, et al. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations. HIV Clin Trials 2002 ; 3 : 27-35. [Google Scholar]
  43. Solas C, Lafeuillade A, Halfon P, et al. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2003 ; 47 : 238-43. [Google Scholar]
  44. Bujan L, Daudin M, Matsuda T, et al. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. Aids 2004 ; 18 : 757-66. [Google Scholar]
  45. Vernazza P, Daneel S, Schiffer V, et al. The role of compartment penetration in PI-monotherapy: the atazanavir-ritonavir monomaintenance (ATARITMO) trial. Aids 2007 ; 21 : 1309-15. [Google Scholar]
  46. Pasquier CJ, Moinard N, Saune K, et al. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract. Aids 2008 ; 22 : 1894-6. [Google Scholar]
  47. Nunnari G, Otero M, Dornadula G, et al. Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infections. Aids 2002 ; 16 : 39-45. [Google Scholar]
  48. Craigo JK, Patterson BK, Paranjpe S, et al. Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy. AIDS Res Hum Retrovir 2004 ; 20 : 1196-209. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.